CTTQ
Status and phase
Conditions
Treatments
About
This is a multicenter, open-label, multi-cohort Phase Ib trial to evaluate the efficacy and safety of TQB2928 injection combined with anlotinib hydrochloride capsule in patients with relapsed/metastatic osteosarcoma and other relapsed/metastatic solid tumors.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Pathological diagnosis of high-grade osteosarcoma(cohort I),dedifferentiated liposarcoma or polytypic liposarcoma(cohort II),unsuitable for local treatment;
The requirements for front-line treatment received by subjects are as follows:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
43 participants in 2 patient groups
Loading...
Central trial contact
Lu Xie, Doctor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal